Protein Kinase C α Is a Central Signaling Node and Therapeutic Target for Breast Cancer Stem Cells
The epithelial-mesenchymal transition program becomes activated during malignant progression and can enrich for cancer stem cells (CSCs). We report that inhibition of protein kinase C α (PKCα) specifically targets CSCs but has little effect on non-CSCs. The formation of CSCs from non-stem cells invo...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Other Authors: | |
Format: | Article |
Published: |
Elsevier
2018
|
Online Access: | http://hdl.handle.net/1721.1/116947 https://orcid.org/0000-0002-0895-3557 |